Grown Rogue International (GRUSF) Cash & Equivalents (QoQ) (2009 - 2026)
Grown Rogue International (GRUSF) Cash & Equivalents (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.02 Bn | 32.28 Bn | 1.97 Bn |
| 3 | Zoetis | 32.60 Bn | 30.66 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.94 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.48% |
| Dec 31, 2025 | -100.00% |
| Sep 30, 2025 | -100.00% |
| Jun 30, 2025 | 139,326,503,117,003.56% |
| Mar 31, 2025 | 98.13% |
| Dec 31, 2024 | -18.23% |
| Sep 30, 2024 | -25.47% |
| Jun 30, 2024 | -21.61% |
| Mar 31, 2024 | 40.36% |
| Oct 31, 2023 | 2.79% |
| Jul 31, 2023 | 67.74% |
| Apr 30, 2023 | 139.44% |
| Jan 31, 2023 | 132,820,470.47% |
| Jan 31, 2022 | 25.72% |
| Oct 31, 2021 | 306.88% |
| Jul 31, 2021 | -87.32% |
| Apr 30, 2021 | 34.34% |
| Jan 31, 2021 | 486.99% |
| Oct 31, 2020 | -63.17% |
| Jul 31, 2020 | -1.34% |